Tackling KRAS^G12C-mutated non-small-cell lung cancer: iteration and exploration

Lancet Respir Med. 2024 Aug;12(8):576-577. doi: 10.1016/S2213-2600(24)00116-4. Epub 2024 Jun 10.

Authors

Jia Luo¹, Liza C Villaruz²

Affiliations

¹ Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
² UPMC Hillman Cancer Center, Pittsburgh, PA 15232, USA. Electronic address: [email protected].

PMID: 38870980
DOI: 10.1016/S2213-2600(24)00116-4

No abstract available

MeSH terms

Carcinoma, Non-Small-Cell Lung* / drug therapy
Carcinoma, Non-Small-Cell Lung* / genetics
Humans
Lung Neoplasms* / genetics
Mutation*
Proto-Oncogene Proteins p21(ras)* / genetics

Substances

Proto-Oncogene Proteins p21(ras)
KRAS protein, human